Posted in | News | Medical Robotics

Medication Robot Provider Announces Compliance with Patient Protection and Affordable Care Act

Health Robotics today announced that, effective January 1, 2013, it will fully comply with The Patient Protection and Affordable Care Act (ACA), including maximum health insurance benefits for its USA-based employees.

Health Robotics is hopeful that its USA-based customers understand the need for small companies such as Health Robotics to transfer these additional operating costs and ACA's mandatory excise [sales] taxes on FDA-regulated medical devices equally to both its USA not-for-profit [tax-exempt customers] and for-profit customers, effective March 1, 2013.

Gaspar DeViedma, Health Robotics' Executive Vice President and Board Member, stated: "Although USA-based operating companies may opt out of certain ACA mandates such as health insurance coverage by hiring part-time employees or by other well documented methods, Health Robotics recently made a decision after the November 6, 2012 elections to fully comply with the ACA given the life-critical nature of our business. In order to offer our prospective customers a reasonable time to obtain approval of their pending budgets, the price increase shall be effective for all contracts/orders received on or after March 1, 2013, with all current quotes expiring thereafter, or subject to price modifications that reflect the ACA."

About Health Robotics:

Founded in 2006 and now reaching well over 80% global market share, Health Robotics is the undisputed leading supplier of life-critical intravenous medication robots, providing over 300 hospital installations in 5 continents with robotics-based technology and fully integrated clinical software automation solutions. Health Robotics' second generation solutions [i.v.STATION, i.v.SOFT, and i.v.STATION ONCO] have been found [through scientific and peer-reviewed studies[1],[2]] to greatly contribute to ease hospitals' growing pressures to improve patient safety[1], increase throughput and contain costs[1]. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' medical devices and integrated workflow solutions help hospitals eliminate life-threatening drug[1] and diluent[1] exchange errors, improve drug potency[2], decrease other medical mistakes and sterility risks, work more efficiently[1], reduce waste and controlled substances' diversion, and diminish the gap between rising patient volume/acuity and scarce medical, nursing, and pharmacy staff.

Source: http://www.health-robotics.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Health Robotics. (2019, February 20). Medication Robot Provider Announces Compliance with Patient Protection and Affordable Care Act. AZoRobotics. Retrieved on April 26, 2024 from https://www.azorobotics.com/News.aspx?newsID=3585.

  • MLA

    Health Robotics. "Medication Robot Provider Announces Compliance with Patient Protection and Affordable Care Act". AZoRobotics. 26 April 2024. <https://www.azorobotics.com/News.aspx?newsID=3585>.

  • Chicago

    Health Robotics. "Medication Robot Provider Announces Compliance with Patient Protection and Affordable Care Act". AZoRobotics. https://www.azorobotics.com/News.aspx?newsID=3585. (accessed April 26, 2024).

  • Harvard

    Health Robotics. 2019. Medication Robot Provider Announces Compliance with Patient Protection and Affordable Care Act. AZoRobotics, viewed 26 April 2024, https://www.azorobotics.com/News.aspx?newsID=3585.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.